Amphastar Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
11570 6th St, Rancho Cucamonga, Californ...Phone Number
(800) 423-4136Website
www.amphastar.comRevenue
$720.5 MillionStock Symbol
AMPHIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Amphastar Pharmaceuticals
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products. In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center. As a commitment to high quality, all Amphastar finished products are manufactured in the United States.Explore more
Amphastar Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amphastar Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Amphastar Pharmaceuticals launches new products
Earning: See what the market has to say on Amphastar Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Amphastar Pharmaceuticals
Check out if Amphastar Pharmaceuticals is spiking on competitors!
Amphastar Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Amphastar Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Amphastar Pharmaceuticals has new funding data
Click to see if Amphastar Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Amphastar Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Amphastar Pharmaceuticals
Compare insights from companies similar to Amphastar Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Amphastar Pharmaceuticals
$720.5M
1K - 5K
Public
$56M
1996
GR
Gregory RiveraVice President, Corporate Controller
Company Profile Activity
Activity Insights
Amphastar Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amphastar Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amphastar Pharmaceuticals.
Amphastar Pharmaceuticals financials insights
Gather financial insights about Amphastar Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$56M
Amphastar Pharmaceuticals Tech Stack
A closer look at the technologies used by Amphastar Pharmaceuticals
Most Recent Scoops
Person-Based
Pricing
Person-Based
Earnings, Finance, Healthcare Operations
Person-Based
Earnings, Financial Reporting, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Events
Amphastar Pharmaceuticals News & Media
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
Amphastar Pharmaceuticals (NASDAQ:AMPH) executives told investors at the Jefferies Healthcare Conference that the company is maintaining expectations for mid- to high-single-digit revenue growth in 2026, supported by a new generic launch, Primatene Mist growth and selected API sales from its China bAmphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Amphastar Pharmaceuticals, Inc. (AMPH) Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDTCompany ParticipantsWilliam Peters - CFO,...Amphastar Pharmaceuticals Q1 Earnings Call Highlights
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported first-quarter 2026 net revenues of approximately $171.2 million, up slightly from $170.5 million in the prior-year period, as recently launched products helped offset pricing pressure and increased competition across parts of its legacy portfolio. OnAmphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference
Amphastar Pharmaceuticals (NASDAQ:AMPH) executives outlined growth drivers, competitive pressures, and pipeline priorities during a fireside chat at Needham & Company’s 25th Annual Healthcare Conference. The discussion featured CFO Bill Peters, Senior VP of Corporate Communications Dan Dischner,
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amphastar Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products. In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe,... Read More
